Sign In
Get Clay Free →

Suggestions

    Eric Wallenstein

    Director, Regulatory CMC Strategy for Cell, Gene and CAR-T Therapies at Bristol-Myers Squibb

    Eric Wallenstein is an accomplished professional with a diverse background in Biomedical Engineering and Regulatory Affairs.

    He holds a Ph.D. and a B.S. in Biomedical Engineering, both from Rutgers University, where he also minored in Economics.

    With an extensive tenure in the pharmaceutical industry, Eric has held key positions at renowned companies such as Bristol-Myers Squibb, Celgene, Merck, and Johnson & Johnson.

    Currently, Eric serves as the Director of Global Regulatory CMC at Bristol-Myers Squibb, showcasing his expertise in regulatory affairs.

    Prior to joining Bristol-Myers Squibb, he held leadership roles at Celgene and various positions at Merck, where he contributed significantly to tech transfer and scientific research.

    His previous experiences include roles at Centocor/Johnson & Johnson, Rutgers University/UMDNJ, and internships at Aventis Pharmaceuticals and Janssen Pharmaceutica.

    Eric's educational background, combined with his extensive professional experience, positions him as a notable figure in the field of biomedical engineering and regulatory compliance.

    Eric Wallenstein
    Add to my network

    Location

    Summit, New Jersey, United States